查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442906

血栓切除设备 - 全球市场回顾、竞争格局、市场预测 (2030)

Thrombectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2024-2030年期间，全球血栓切除设备市场规模将以5.24%的复合年增长率大幅成长。低血压、糖尿病、肥胖和老化等生活方式相关疾病的日益普及推动了对血栓清除设备的需求。此外，静脉血栓栓塞、心血管疾病、癌症以及缺血性和出血性中风等神经系统疾病以及周围性疾病的盛行率不断增加，导致血栓的形成，增加了对血栓清除设备的需求，这将导致增加。此外，对微创治疗方法的需求增加、身体活动不足、吸烟增加、设备推出和批准增加、产品开发快速创新、使用先进技术开发产品以及关键参与者的重点转向努力提高对血管疾病及其预防等的认识正在促进2024-2030年预测期内血栓切除设备市场的整体成长。

血栓清除器市场动态

由于多种因素，血栓清除装置市场的产品需求正在成长，其中主要因素之一是静脉血栓栓塞盛行率的增加。

例如，根据美国疾病管制与预防中心 (CDC) (2023) 的数据，预计美国每年约有 90 万人将患有深部静脉栓塞 (DVT) 或肺栓塞 (PE)。此外，近三分之一到二分之一的静脉血栓 (DVT) 或肺栓塞 (PE) 患者会出现长期併发症，例如受影响肢体肿胀、疼痛、变色和脱皮（血栓后） .症候群） 。

《英国血栓形成》(Thrombosis UK，2023) 指出，在欧洲和美国，每 37 秒就有一人死于静脉血栓栓塞 (VTE)。此外，近 55-60% 的 VTE 病例发生在住院期间或住院后。因此，静脉血栓栓塞盛行率的增加增加了对用于治疗静脉血栓栓塞的设备（例如血栓清除设备）的需求，从而推动了整体市场的成长。

神经血栓切除装置对于治疗缺血性中风（老年人常见的中风现象）至关重要。中风是导致老年人残疾的主要原因之一，大约65%的患者中风后需要身体帮助或支持。根据世界中风组织（2023）的数据，在全球范围内，25岁以上的成年人中四分之一的人一生中会发生中风，超过1.1亿人经历过中风。根据世界卫生组织（WHO）（2023）估计，全球每年有1500万人患有中风，其中500万人死亡，另有500万人留下后遗症，给家庭和社区带来负担。我正在申请。神经血栓切除术是急性缺血性中风的首选治疗方法，因为它可以改善患者的功能结果并降低死亡率。

因此，中风盛行率的增加增加了市场上对血栓清除装置的需求。

缺血性中风的日益普及需要将尖端产品引入市场。该市场是由与缺血性中风相关的新型抽吸装置、血栓取出装置和抽吸导管的开发和推出所推动的。例如，为了推进急性缺血性中风的治疗，Phenox GmbH 于 2021 年在全球推出了 pRESET 6-50 机械血栓切除装置。

此外，2022 年 4 月，Penumbra 的 Indigo 抽吸系统采用 Lightning 7 和 Lightning 12 机械血栓切除技术获得了 CE 标誌。这两项技术旨在一次清除週边动脉和静脉系统的血栓，包括肺栓塞治疗。

因此，上述因素将促进 2024-2030 年预测期内血栓切除设备市场的成长。

然而，与设备相关的併发症、严格的监管环境等可能会限制未来几年血栓切除设备市场的成长。

本报告提供了全球血栓切除设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章血栓切除设备市场报告介绍

第二章血栓切除设备市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章血栓切除设备市场关键因素分析

  • 血栓切除设备市场驱动因素
  • 血栓切除器械市场的限制与挑战
  • 血栓切除装置的市场机会

第五章血栓切除设备市场的波特五力分析

第六章 血栓切除设备市场布局

  • 依产品
    • 抽吸血栓清除装置
    • 机械取栓装置
    • 超音波取栓装置
    • 其他
  • 依用途
    • 心血管血栓切除术
    • 神经血管血栓切除术
    • 週边血块清除
  • 依最终用户
    • 医院/诊所
    • 门诊手术中心
  • 区域
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第 7 章：血栓切除装置市场公司与产品概况

  • Koninklijke Philips N.V.
  • Terumo Corporation
  • Medtronic
  • Boston Scientific Corporation
  • Penumbra, Inc.
  • Thrombolex
  • Imperative Care Inc.
  • Stryker
  • Argon Medical Devices Inc.
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • BD
  • phenox GmbH
  • DSMAREF CO.LTD
  • Teleflex Incorporated
  • AngioDynamics
  • Abbott
  • inari medical
  • Merit Medical Systems
  • Acandis GmbH

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明，联络我们

Product Code: DIMDCL0692

Thrombectomy Devices Market By Product (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, And Others), Application (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, And Peripheral Vascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of blood clots owing to rising prevalence of various cardiovascular and neurological diseases and the growing figures of various risk factors such as obesity, age, and others

The global thrombectomy devices market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.24% during the forecast period from 2024 to 2030. The demand for thrombectomy devices is being boosted by the increasing prevalence of lifestyle disorders such as low blood pressure, diabetes, obesity, age, and others. Further, the increasing prevalence of venous thromboembolism, cardiovascular diseases, cancer, and neurological diseases such as ischemic stroke, hemorrhagic stroke, and peripheral diseases, among others will lead to the formation of blood clots, thereby leading to the increased demand for thrombectomy devices. In addition, the increasing demand for minimally invasive approaches for treatment, lack of physical activity, rising adoption of smoking, rising device launches and approvals, surging innovations in product development, and shifting key players' focus towards the development of technologically advanced product and initiatives to increase awareness regarding neurovascular diseases and their prevention among others are thereby contributing to the overall growth of the thrombectomy devices market during the forecast period from 2024-2030.

Thrombectomy Devices Market Dynamics:

The thrombectomy devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of venous thromboembolism.

For instance, as per the Centers for Disease Control and Prevention (CDC) 2023, it was estimated that approximately 900,000 people could be affected by deep vein thrombosis (DVT) or pulmonary embolism (PE) each year in the United States. Further, nearly one-third to one-half of people suffering from vein thrombosis (DVT) or pulmonary embolism (PE) may have long-term complications (post-thrombotic syndrome) such as swelling, pain, discoloration, and scaling in the affected limb.

Thrombosis UK (2023), stated that every 37 seconds someone in the Western world dies from venous thromboembolism (VTE). Also, nearly 55 to 60 percent of VTE cases occur during or following hospitalization. Thus, the increasing prevalence of venous thromboembolism will increase the demand for devices used in the treatment of venous thromboembolism such as thrombectomy devices, thereby propelling the overall market growth.

Neurothrombectomy devices are critical in treating ischemic stroke, a commonly occurring phenomenon of stroke among older adults. Stroke is one of the leading causes of disability among the elderly with around 65% of patients requiring physical assistance or support post an episode of stroke. As per the source, World Stroke Organization 2023, stated that globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime and over 110 million people in the world have experienced stroke. The World Health Organization (WHO) 2023, estimated that annually, 15 million people worldwide suffer a stroke and of these, 5 million die, and another 5 million are left permanently disabled, placing a burden on family and community. Since the neurothrombectomy procedure improves functional outcomes and lowers the mortality rate in patients, therefore, it is the most preferred treatment for acute ischemic stroke.

Thus, the increasing prevalence of stroke will increase the demand for thrombectomy devices in the market.

The need to introduce cutting-edge items to the market has been brought on by the rise in ischemic stroke incidence. The market is driven by the development and introduction of new ischemic stroke-related suction devices, clot retrievers, and aspiration catheters. For instance, to advance its technique for acute ischemic stroke, Phenox GmbH launched pRESET 6-50 mechanically thrombectomy devices globally in 2021.

Also, in April 2022, Penumbra obtained a CE Mark for its Indigo Aspiration System with Lightning 7 and Lightning 12 mechanical thrombectomy technologies. The two technologies are designed for the removal of single-session blood clot in peripheral arterial and venous systems, including the pulmonary embolisms treatment.

Therefore, the above-mentioned factors are contributing to the growth of the thrombectomy devices market during the forecast period from 2024-2030.

However, device-related complications, stringent regulatory scenarios, and others may restrict the thrombectomy devices market growth in the upcoming years.

Thrombectomy Devices Market Segment Analysis:

Thrombectomy Devices Market by Product (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, and Others), Application (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, and Peripheral Vascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Rest of the World)

In the product segment of the thrombectomy devices market, the mechanical thrombectomy category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the applications and advantages related to the segment.

Mechanical thrombectomy is a type of minimally invasive procedure in which an interventional radiologist uses specialized equipment to remove a clot from a patient's artery. It is a new technique of stroke treatment that eliminates blood clots from the brain's major blood arteries. Patients who experienced an acute ischemic stroke brought on by a significant artery blockage in the anterior circulation of the brain are advised to undergo the mechanical thrombectomy procedure.

When combined with a type of systemic thrombolytic agent and other medical procedures, mechanical thrombectomy greatly reduces the number of patients who experience stroke-related impairments. During the forecast period, demand for mechanical thrombectomy devices is anticipated to increase due to the rise in demand for less invasive surgical procedures and favorable reimbursement policies for cardiovascular and neurovascular operations.

Furthermore, various companies are conducting research and development related to mechanical thrombectomy devices to increase their product portfolio. For instance, in May 2023, Akura Medical, a Shifamed portfolio company initiated its first-in-human clinical study of the Akura Mechanical Thrombectomy Platform. The Akura platform is a low-profile solution designed to easily access and efficiently remove large volume, mixed morphology clots, and eliminate the guesswork around the procedure.

Also, in July 2021, Surmodics, Inc., acquired privately held Vetex Medical Limited, an Ireland-based medical device developer and manufacturer. The transaction expands Surmodics' thrombectomy portfolio with a second U.S. Food and Drug Administration (FDA) 510(k)-cleared device, the ReVene(TM) Thrombectomy Catheter. The ReVene mechanical thrombectomy catheter is designed to remove large, mixed-morphology blood clots commonly found with venous thromboembolism (VTE).

Therefore, the advantages offered by mechanical thrombectomy are predicted to contribute to the increasing demand for this product, thereby driving the growth of the overall thrombectomy devices market during the forecast period.

North America is expected to dominate the overall Thrombectomy Devices Market:

Among all the regions, North America is estimated to account for the largest share of the thrombectomy devices market in the year 2023. Owing to the significance of key growth factors including the rising prevalence of cancers, neurological diseases, cardiovascular diseases, venous thromboembolism, and others, the rising burden of the geriatric population base prone to afore-said diseases, the increasing number of obese people, early adoption of new technologies, innovative technologies and infrastructure resulting in significant healthcare facilities and patient care, increase in investments by government & private institutions, and escalating regulatory approvals among others, the North America thrombectomy devices market is expected to witness positive growth.

For instance, as per CDC 2023, one-third (about 33%) of people suffering from deep vein thrombosis (DVT) or pulmonary embolism (PE) in the US will have a recurrence of the disease within 10 years.

According to the CDC 2021 report, every year, more than 795,000 people in the United States have a stroke and about 610,000 of these are first or new strokes. In addition, the report also stated that 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

The above sources, clearly indicate that the prevalence of cardiovascular diseases and neurological diseases is surging in the region, ultimately increasing the demand for thrombectomy devices which are used for the management or treatment of the aforementioned diseases.

Coupled with the factors mentioned above, the increasing regulatory approvals and launches in the region will also drive the market of thrombectomy devices. For instance, in August 2021, Stryker Neurovascular received the US FDA approval for their Trevo NXT Pro Vue Retriever, a class II medical device classified as a neurovascular mechanical thrombectomy device for acute ischemic stroke.

Also, in February 2020, Stryker received the US FDA approval for Trevo NXT ProVue Retriever indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke.

Thus, such strategic steps help to increase the demand for thrombectomy devices, thereby driving the North America thrombectomy devices market forward during the forecast period.

Thrombectomy Devices Market Key Players:

Some of the key market players operating in the thrombectomy devices market include Koninklijke Philips N.V., Terumo Corporation, Medtronic, Boston Scientific Corporation, Penumbra, Inc., Thrombolex, Imperative Care Inc., Stryker, Argon Medical Devices Inc., Edwards Lifesciences Corporation, Johnson & Johnson, BD, phenox GmbH, DSMAREF CO.LTD, Teleflex Incorporated, AngioDynamics, Abbott, inari medical, Merit Medical Systems, Acandis GmbH, and others.

Recent Developmental Activities in the Thrombectomy Devices Market:

  • In September 2022, Vesalio announced European CE Mark approval of the company's NeVa Net thrombectomy device, which features integrated clot microfiltration technology.
  • In September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.
  • In May 2020, Control Medical Technology obtained the US Food and Drug Administration (FDA) approval for its Aspire MAX 7 - 11F Mechanical Thrombectomy platform. Aspire MAX 7 - 11F Mechanical Thrombectomy platform has been designed to remove blood clots from the peripheral vessels.

Key Takeaways from the Thrombectomy Devices Market Report Study

  • Market size analysis for current thrombectomy devices market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global thrombectomy devices market
  • Various opportunities are available for the other competitors in the thrombectomy devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current thrombectomy devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for thrombectomy devices market growth in the coming future?

Target Audience who can be benefited from this Thrombectomy Devices Market Report Study

  • Thrombectomy devices providers
  • Research organizations and consulting companies
  • Thrombectomy devices -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in thrombectomy devices
  • Various End-users who want to know more about the thrombectomy devices market and the latest technological developments in the thrombectomy devices market.

Frequently Asked Questions for the Thrombectomy Devices Market:

1. What are thrombectomy devices?

Thrombectomy is an interventional procedure performed to remove clots from a blood vessel. It is commonly performed in coronary arteries, peripheral arteries, and cerebral arteries.

2. What is the market for global thrombectomy devices?

The global thrombectomy devices market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.24% during the forecast period from 2024 to 2030.

3. What are the drivers for the global thrombectomy devices market?

The demand for thrombectomy devices is primarily being heightened by the rising cases of cardiovascular diseases and cancers, the growing prevalence of neurological disorders such as acute ischemic stroke, and hemohragic stroke, the rising number of obese and geriatric population, rising product launches and approvals, along with a growing number of research and development activities, thereby contributing to the overall growth of thrombectomy devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global thrombectomy devices market?

Some of the key market players operating in the thrombectomy devices market include Koninklijke Philips N.V., Terumo Corporation, Medtronic, Boston Scientific Corporation, Penumbra, Inc., Thrombolex, Imperative Care Inc., Stryker, Argon Medical Devices Inc., Edwards Lifesciences Corporation, Johnson & Johnson, BD, phenox GmbH, DSMAREF CO.LTD, Teleflex Incorporated, AngioDynamics, Abbott, inari medical, Merit Medical Systems, Acandis GmbH, and others.

5. Which region has the highest share in the thrombectomy devices market?

North America is expected to dominate the overall thrombectomy devices market during the forecast period from 2024-2030.

Factors such as the rising prevalence of venous thromboembolism, cardiovascular diseases, neurovascular, and peripheral diseases, among others, the rising geriatric population, technological advancements in medical devices used for capturing blood clots, the presence of key players in the region, and the escalating regulatory approvals are said to drive the growth of North America thrombectomy devices market.

Table of Contents

1. Thrombectomy Devices Market Report Introduction

2. Thrombectomy Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Thrombectomy Devices Market Key Factors Analysis

  • 4.1. Thrombectomy Devices Market Drivers
    • 4.1.1. Rising prevalence of blood clots owing to cardiovascular diseases, neurological disorders, and trauma cases among others
    • 4.1.2. Growing geriatric population
    • 4.1.3. Rise in adoption of automated thrombectomy devices
  • 4.2. Thrombectomy Devices Market Restraints and Challenges
    • 4.2.1. Device-related complications
    • 4.2.2. Stringent Regulatory Scenario
  • 4.3. Thrombectomy Devices Market Opportunities
    • 4.3.1. Combined thrombolytic and mechanical approaches

5. Thrombectomy Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Thrombectomy Devices Market Layout

  • 6.1. By Product
    • 6.1.1. Aspiration Thrombectomy Devices
    • 6.1.2. Mechanical Thrombectomy Devices
    • 6.1.3. Ultrasonic Thrombectomy Devices
    • 6.1.4. Others
  • 6.2. By Applications
    • 6.2.1. Cardiovascular Thrombectomy
    • 6.2.2. Neurovascular Thrombectomy
    • 6.2.3. Peripheral Vascular Thrombectomy
  • 6.3. By End-User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Thrombectomy Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Thrombectomy Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Thrombectomy Devices Market Size in USD million (2021-2030)

7. Thrombectomy Devices Market Company and Product Profiles

  • 7.1. Koninklijke Philips N.V.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Terumo Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Medtronic
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Boston Scientific Corporation
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Penumbra, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Thrombolex
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Imperative Care Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Stryker
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Argon Medical Devices Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Edwards Lifesciences Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Johnson & Johnson
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. BD
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. phenox GmbH
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. DSMAREF CO.LTD
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Teleflex Incorporated
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. AngioDynamics
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Abbott
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. inari medical
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Merit Medical Systems
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Acandis GmbH
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Thrombectomy Devices Market in Global (2021-2030)
  • Table 3: Thrombectomy Devices Market in Global by Product (2021-2030)
  • Table 4: Thrombectomy Devices Market in Global by Application (2021-2030)
  • Table 5: Thrombectomy Devices Market in Global by End-User (2021-2030)
  • Table 6: Thrombectomy Devices Market in Global by Geography (2021-2030)
  • Table 7: Thrombectomy Devices Market in North America (2021-2030)
  • Table 8: Thrombectomy Devices Market in the US (2021-2030)
  • Table 9: Thrombectomy Devices Market in Canada (2021-2030)
  • Table 10: Thrombectomy Devices Market in Mexico (2021-2030)
  • Table 11: Thrombectomy Devices Market in Europe (2021-2030)
  • Table 12: Thrombectomy Devices Market in France (2021-2030)
  • Table 13: Thrombectomy Devices Market in Germany (2021-2030)
  • Table 14: Thrombectomy Devices Market in the United Kingdom (2021-2030)
  • Table 15: Thrombectomy Devices Market in Italy (2021-2030)
  • Table 16: Thrombectomy Devices Market in Spain (2021-2030)
  • Table 17: Thrombectomy Devices Market in the Rest of Europe (2021-2030)
  • Table 18: Thrombectomy Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Thrombectomy Devices Market in China (2021-2030)
  • Table 20: Thrombectomy Devices Market in Japan (2021-2030)
  • Table 21: Thrombectomy Devices Market in India (2021-2030)
  • Table 22: Thrombectomy Devices Market in Australia (2021-2030)
  • Table 23: Thrombectomy Devices Market in South Korea (2021-2030)
  • Table 24: Thrombectomy Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Thrombectomy Devices Market in the Rest of the World (2021-2030)
  • Table 26: Thrombectomy Devices Market in the Middle East (2021-2030)
  • Table 27: Thrombectomy Devices Market in Africa (2021-2030)
  • Table 28: Thrombectomy Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Thrombectomy Devices Market in Global (2021-2030)
  • Figure 3: Thrombectomy Devices Market in Global by Product (2021-2030)
  • Figure 4: Thrombectomy Devices Market in Global by Application (2021-2030)
  • Figure 5: Thrombectomy Devices Market in Global by End-User (2021-2030)
  • Figure 6: Thrombectomy Devices Market in Global by Geography (2021-2030)
  • Figure 7: Thrombectomy Devices Market in North America (2021-2030)
  • Figure 8: Thrombectomy Devices Market in the US (2021-2030)
  • Figure 9: Thrombectomy Devices Market in Canada (2021-2030)
  • Figure 10: Thrombectomy Devices Market in Mexico (2021-2030)
  • Figure 11: Thrombectomy Devices Market in Europe (2021-2030)
  • Figure 12: Thrombectomy Devices Market in France (2021-2030)
  • Figure 13: Thrombectomy Devices Market in Germany (2021-2030)
  • Figure 14: Thrombectomy Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Thrombectomy Devices Market in Italy (2021-2030)
  • Figure 16: Thrombectomy Devices Market in Spain (2021-2030)
  • Figure 17: Thrombectomy Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Thrombectomy Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Thrombectomy Devices Market in China (2021-2030)
  • Figure 20: Thrombectomy Devices Market in Japan (2021-2030)
  • Figure 21: Thrombectomy Devices Market in India (2021-2030)
  • Figure 22: Thrombectomy Devices Market in Australia (2021-2030)
  • Figure 23: Thrombectomy Devices Market in South Korea (2021-2030)
  • Figure 24: Thrombectomy Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Thrombectomy Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Thrombectomy Devices Market in the Middle East (2021-2030)
  • Figure 27: Thrombectomy Devices Market in Africa (2021-2030)
  • Figure 28: Thrombectomy Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis